AAAAAA
Results:
1-15
|
Results: 15
Authors:
Leppla, SH
Citation: Sh. Leppla, A dominant-negative therapy for anthrax - The oligomeric structure of anthrax toxin might be exploited as a preventative or therapeutic vaccine., NAT MED, 7(6), 2001, pp. 659-660
Authors:
Pannifer, AD
Wong, TY
Schwarzenbacher, R
Renatus, M
Petosa, C
Bienkowska, J
Lacy, DB
Collier, RJ
Park, S
Leppla, SH
Hanna, P
Liddington, RC
Citation: Ad. Pannifer et al., Crystal structure of the anthrax lethal factor, NATURE, 414(6860), 2001, pp. 229-233
Authors:
Duesbery, NS
Resau, J
Webb, CP
Koochekpour, S
Koo, HM
Leppla, SH
Woude, GFV
Citation: Ns. Duesbery et al., Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways, P NAS US, 98(7), 2001, pp. 4089-4094
Authors:
Liu, SH
Bugge, TH
Leppla, SH
Citation: Sh. Liu et al., Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin, J BIOL CHEM, 276(21), 2001, pp. 17976-17984
Authors:
Price, BM
Liner, AL
Park, S
Leppla, SH
Mateczun, A
Galloway, DF
Citation: Bm. Price et al., Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein, INFEC IMMUN, 69(7), 2001, pp. 4509-4515
Authors:
Park, S
Leppla, SH
Citation: S. Park et Sh. Leppla, Optimized production and purification of Bacillus anthracis lethal factor, PROT EX PUR, 18(3), 2000, pp. 293-302
Authors:
Leppla, SH
Citation: Sh. Leppla, Anthrax toxin, HANDB EXP P, 145, 2000, pp. 445-472
Authors:
Liu, SH
Netzel-Arnett, S
Birkedal-Hansen, H
Leppla, SH
Citation: Sh. Liu et al., Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin, CANCER RES, 60(21), 2000, pp. 6061-6067
Authors:
Leppla, SH
Arora, N
Varughese, M
Citation: Sh. Leppla et al., Anthrax toxin fusion proteins for intracellular delivery of macromolecules, J APPL MICR, 87(2), 1999, pp. 284-284
Authors:
Gu, ML
Leppla, SH
Klinman, DM
Citation: Ml. Gu et al., Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen, VACCINE, 17(4), 1999, pp. 340-344
Authors:
Gordon, VM
Nelson, KL
Buckley, JT
Stevens, VL
Tweten, RK
Elwood, PC
Leppla, SH
Citation: Vm. Gordon et al., Clostridium septicum alpha toxin uses glycosylphosphatidylinositol-anchored protein receptors, J BIOL CHEM, 274(38), 1999, pp. 27274-27280
Authors:
Tang, GQ
Leppla, SH
Citation: Gq. Tang et Sh. Leppla, Proteasome activity is required for anthrax lethal toxin to kill macrophages, INFEC IMMUN, 67(6), 1999, pp. 3055-3060
Authors:
Singh, Y
Klimpel, KR
Goel, S
Swain, PK
Leppla, SH
Citation: Y. Singh et al., Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells, INFEC IMMUN, 67(4), 1999, pp. 1853-1859
Authors:
Varughese, M
Teixeira, AV
Liu, SH
Leppla, SH
Citation: M. Varughese et al., Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin, INFEC IMMUN, 67(4), 1999, pp. 1860-1865
Authors:
Abrami, L
Fivaz, M
Decroly, E
Seidah, NG
Jean, F
Thomas, G
Leppla, SH
Buckley, JT
van der Goot, FG
Citation: L. Abrami et al., The pore-forming toxin proaerolysin is activated by furin, J BIOL CHEM, 273(49), 1998, pp. 32656-32661
Risultati:
1-15
|